INHIBRX BIOSCIENCES

Live / Applied — Second extension granted (statement of use) (as of 03 Nov 2025)

What this means for you

Not registered yet, but its 08 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98440219
Mark type
Stylized text
Filed
08 Mar 2024
Published for opposition
12 Nov 2024
Attorney of record
Andrew D. Skale

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances used for the treatment of cancer, autoimmune disorders, and inflammatory diseases and conditions; Genetically engineered proteins for diagnostic purposes; Gene proteins, namely, antibodies and fusion proteins for the treatment of cancer, autoimmune disorders, and inflammatory diseases and conditions; Pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; Biochemicals, namely, engineered proteins for the regulation of animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment and diagnostic of cancer, autoimmune disorders, and inflammatory diseases and conditions

Owner

Prior registrations

Prosecution history

  • 03 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Nov 2025 — SOU EXTENSION 2 GRANTED
  • 03 Nov 2025 — SOU EXTENSION 2 FILED
  • 03 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 15 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 15 May 2025 — SOU EXTENSION 1 GRANTED
  • 15 May 2025 — SOU EXTENSION 1 FILED
  • 15 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 12 Nov 2024 — PUBLISHED FOR OPPOSITION
  • 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 02 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 02 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
  • 02 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

View this trademark record on Marksy